Jennison Associates LLC’s Dexcom Inc Position
Does Jennison Associates LLC own Dexcom Inc (DC4)? Yes — 1.05M shares worth $66M (+0.05% of its 13F portfolio) as of Q1 2026, down from 5.79M shares the prior filed quarter.
Position Value
$66M
Q1 2026
Shares
1.05M
% of Portfolio
+0.05%
Quarters Held
30
currently held
Position History DC4
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 1.05M | $66M | +0.05% |
| Q4 2025 | 5.79M | $384M | +0.23% |
| Q3 2025 | 10.09M | $679M | +0.40% |
| Q2 2025 | 11.52M | $1.0B | +0.60% |
| Q1 2025 | 10.52M | $719M | +0.50% |
| Q4 2024 | 7.64M | $594M | +0.36% |
| Q3 2024 | 6.93M | $465M | +0.29% |
| Q2 2024 | 388.8K | $44M | +0.03% |
| Q1 2024 | 388.3K | $54M | +0.04% |
| Q4 2023 | 378.1K | $47M | +0.03% |
| Q3 2023 | 4.29M | $400M | +0.34% |
| Q2 2023 | 7.28M | $936M | +0.77% |
| Q1 2023 | 7.26M | $844M | +0.77% |
| Q4 2022 | 9.19M | $1.0B | +1.05% |
| Q3 2022 | 6.94M | $559M | +0.56% |
| Q2 2022 | 8.56M | $638M | +0.64% |
| Q1 2022 | 2.60M | $1.3B | +0.98% |
| Q4 2021 | 1.42M | $761M | +0.48% |
| Q3 2021 | 1.54M | $844M | +0.55% |
| Q2 2021 | 1.60M | $682M | +0.45% |
| Q1 2021 | 1.70M | $611M | +0.45% |
| Q4 2020 | 1.99M | $736M | +0.52% |
| Q3 2020 | 2.74M | $1.1B | +0.91% |
| Q2 2020 | 2.76M | $1.1B | +1.01% |
| Q1 2020 | 2.69M | $725M | +0.88% |
| Q4 2019 | 3.46M | $757M | +0.76% |
| Q3 2019 | 4.04M | $603M | +0.64% |
| Q2 2019 | 1.39M | $209M | +0.21% |
| Q1 2019 | 447.3K | $53M | +0.05% |
| Q4 2018 | 434.4K | $52M | +0.06% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Jennison Associates LLC’s full portfolio or all institutional holders of DC4.